Accepted for Publication: December 8, 2013.
Published Online: July 23, 2014. doi:10.1001/jamadermatol.2013.10526.
Study concept and design: Mackay-Wiggan.
Acquisition, analysis, or interpretation of data: All authors.
Drafting of the manuscript: Thompson, Furniss, Mackay-Wiggan.
Critical revision of the manuscript for important intellectual content: All authors.
Statistical analysis: Thompson, Zhao, Chakraborty.
Obtained funding: Mackay-Wiggan.
Administrative, technical, or material support: Thompson.
Study supervision: Mackay-Wiggan.
Conflict of Interest Disclosures: Dr Mackay-Wiggan reports receiving a research grant from Celgene Corporation. No other disclosures were reported.
Funding/Support: This study was funded in its entirety by an investigator-initiated research grant from Celgene Corporation.
Role of the Sponsor: Celgene Corporation reviewed the manuscript but had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation or approval of the manuscript; and decision to submit the manuscript for publication.
Additional Contributions: Julissa Borbon, BA, supported the work of this trial by serving as our administrative coordinator; Grace Ulerio, BA, and Carol Coppola, RN, by serving as our clinical coordinators; and Jackleen Marji, MD, PharmD, by serving as our clinical research fellow (all are with Columbia University). None received direct financial compensation; funds were paid to Columbia University to cover study costs.